Online citations, reference lists, and bibliographies.
← Back to Search

Lipids As Biological Materials For Nanoparticulate Delivery

I. P. Kaur, R. Bhandari, J. V. Yakhmi
Published 2014 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Lipid-based drug delivery has been an ever-growing field of research these last few decades right from its inception as fat emulsion(s) for parenteral nutrition in the past to the present day targeted delivery of drugs. Lipid-based nanosystems constitute liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and self-nanoemulsifying drug delivery systems (SNEDDS). Use of lipids for improving the bioavailability and solubility of drugs and advantages like biocompatibility, lesser susceptibility to erosion phenomena, and slower water uptake makes them the ideal choice for delivering therapeutics in a controlled and targeted manner. Present chapter comprehensively covers the available lipids and excipients including emulsifiers used in the preparation of these lipid nanoparticle their method of preparation and factors affecting their performance characteristics. Also included are the major characterization parameters, pharmacokinetic behavior, and ways to improve bioperformance and targetability of these nanomaterials. Safety issues and specialized application in gene delivery are also touched upon in the end.
This paper references
Preparation and Characterization of Bis-ethylhexyloxyphenolmethoxyphenyltriazine (BEMT) Loaded Solid Lipid Nano-particles (SLN)
Geun-Soo Lee (2007)
10.1146/annurev-bioeng-071910-124709
In vivo delivery of RNAi with lipid-based nanoparticles.
L. Huang (2011)
10.1080/10611860902718672
Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement
Baboota Sanjula (2009)
10.1016/J.JCONREL.2004.01.002
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.
M. Oyewumi (2004)
10.1016/S0378-5173(97)00135-X
Liposomes in drug delivery: Progress and limitations
Amarnath Sharma (1997)
10.5772/54270
Polylipid Nanoparticle, a Novel Lipid-Based Vector for Liver Gene Transfer
Yahan Fan (2013)
10.1021/cr800409e
Nonviral vectors for gene delivery.
Meredith A. Mintzer (2009)
10.2174/156720106776359230
A review of nanocarrier-based CNS delivery systems.
S. Tiwari (2006)
10.1002/ijc.20048
Chemotherapy of glioblastoma in rats using doxorubicin‐loaded nanoparticles
S. C. Steiniger (2004)
10.1016/S0168-3659(01)00354-6
Lipid microparticles as a parenteral controlled release device for peptides.
H. Reithmeier (2001)
10.1016/J.JCONREL.2006.05.010
Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.
Yifan Luo (2006)
10.1016/j.colsurfb.2011.02.011
Catanionic solid lipid nanoparticles carrying doxorubicin for inhibiting the growth of U87MG cells.
Y. Kuo (2011)
10.1002/smll.200900005
Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
F. Lu (2009)
10.1208/s12249-010-9563-0
Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery
S. Das (2010)
10.1016/J.IJPHARM.2004.10.026
Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system.
Deepika Aggarwal (2005)
10.1080/10611860290031840
Uptake of Cationized Albumin Coupled Liposomes by Cultured Porcine Brain Microvessel Endothelial Cells and Intact Brain Capillaries
M. Thöle (2002)
10.1016/j.colsurfb.2010.11.037
Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
Y. Kuo (2011)
10.1023/A:1022219003551
Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells
J. Panyam (2004)
10.1002/CHIN.200212298
Pharmaceutical applications of supercritical carbon dioxide.
C. S. Kaiser (2001)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
10.1602/neurorx.2.1.108
Drug transport to brain with targeted nanoparticles
J. Olivier (2011)
Preparation and Characterization of Nano-Liposomes Using Phosphatidylcholine
Ki-choon Kang (2005)
10.1016/j.fct.2011.08.006
Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain.
V. Kakkar (2011)
10.1016/j.ijpharm.2013.02.012
Encapsulation of Rifampicin in a solid lipid nanoparticulate system to limit its degradation and interaction with Isoniazid at acidic pH.
H. Singh (2013)
10.5772/50194
Gene Therapy Tools And Potential Applications
Francisco Martín Molina (2014)
10.1016/S0939-6411(97)00150-1
Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.
A. Zur Mühlen (1998)
10.1016/S0378-5173(96)04822-3
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
R. Cavalli (1997)
10.1016/j.bcp.2012.01.008
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer.
C. Hu (2012)
10.1073/pnas.0801763105
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton (2008)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1080/02652040600788080
Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model
Alessandra Ambruosi (2006)
10.1016/0378-5173(93)90177-H
Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction
K. Westesen (1993)
10.1021/NL052396O
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.
B. Chithrani (2006)
10.1016/j.nano.2008.08.003
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Rishi Paliwal (2009)
Handbook of Pharmaceutical Excipients
R. C. Rowe (1994)
10.1016/S0378-5173(00)00614-1
Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.
T. R. Kommuru (2001)
10.1016/J.COCIS.2010.11.003
Challenges facing colloidal delivery systems: From synthesis to the clinic
A. Johnston (2011)
10.3109/10717544.2012.690002
In vivo controlled release and prolonged antitumor effects of 2-methoxyestradiol solid lipid nanoparticles incorporated into a thermosensitive hydrogel
X. Guo (2012)
10.1016/S0378-5173(03)00135-2
Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique.
M. Trotta (2003)
10.2147/IJN.S31537
Preparation and characterization of vinculin-targeted polymer–lipid nanoparticle as intracellular delivery vehicle
Junping Wang (2013)
10.1016/0378-5173(94)90271-2
Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs
N. Shah (1994)
10.1016/j.colsurfb.2010.12.024
The size of solid lipid nanoparticles: an interpretation from experimental design.
Carla Vitorino (2011)
10.1023/A:1012098005098
Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles
R. Alyautdin (2004)
10.1023/B:PHAM.0000003374.58641.62
In Situ Blood–Brain Barrier Transport of Nanoparticles
J. Koziara (2004)
10.1021/JS960085V
Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH.
W. Charman (1997)
10.1016/J.IJPHARM.2006.08.007
Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.
J. Liu (2007)
10.1080/01932690802540517
New Values of the Required Hydrophilic-Lipophilic Balance for Oil in Water Emulsions of Solid Fatty Acids and Alcohols Obtained from Solubility Parameter and Dielectric Constant Values
R. Pasquali (2009)
10.1016/0378-5173(95)04286-5
Crystallization tendency and polymorphic transitions in triglyceride nanoparticles
H. Bunjes (1996)
10.1016/S0939-6411(01)00176-X
The effect of formulation and concentration of cholesteryl butyrate solid lipid nanospheres (SLN) on NIH-H460 cell proliferation.
E. Ugazio (2001)
10.1016/0378-5173(92)90303-J
Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate
B. Sjoestroem (1992)
10.1016/j.jconrel.2007.12.018
Potential of solid lipid nanoparticles in brain targeting.
I. P. Kaur (2008)
10.1016/j.ijpharm.2011.12.037
Loading hydrophilic drug in solid lipid media as nanoparticles: statistical modeling of entrapment efficiency and particle size.
M. Ghadiri (2012)
10.1080/03639040802130061
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
M. Muchow (2008)
10.1016/j.jconrel.2012.04.009
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery".
E. Mahon (2012)
10.1016/J.JCONREL.2005.07.023
Preparation of solid lipid nanoparticles using a membrane contactor.
C. Charcosset (2005)
10.1016/j.jconrel.2009.03.002
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones.
Anja Zensi (2009)
10.1038/APS.2010.15
A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery
J. Li (2010)
10.1016/J.JCONREL.2003.08.006
Brain uptake of thiamine-coated nanoparticles.
P. Lockman (2003)
10.1016/J.JCONREL.2005.01.003
Novel sustained release microspheres for pulmonary drug delivery.
R. O. Cook (2005)
10.1146/annurev-bioeng-071811-150124
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
10.1016/j.jconrel.2011.07.028
Circulation kinetics and biodistribution of dual-labeled polymersomes with modulated surface charge in tumor-bearing mice: comparison with stealth liposomes.
J. Lee (2011)
10.1016/j.ddtec.2011.12.001
Overcoming poor oral bioavailability using nanoparticle formulations - opportunities and limitations.
Preshita P Desai (2012)
10.1016/S0169-409X(00)00122-8
Nanoparticulate systems for brain delivery of drugs.
J. Kreuter (2001)
10.1016/J.ADDR.2012.09.021
Solid lipid nanoparticles
W. Mehnert (2012)
10.3390/pharmaceutics4040641
SNEDDS Containing Poorly Water Soluble Cinnarizine; Development and in Vitro Characterization of Dispersion, Digestion and Solubilization
A. T. Larsen (2012)
10.1016/j.ejps.2009.12.004
Preparation and in vitro-in vivo evaluation of Witepsol H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q(10).
Pushp R Nepal (2010)
10.1016/j.ijpharm.2012.11.042
Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles.
R. Bhandari (2013)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1023/A:1016268311867
Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects
P. Constantinides (2004)
10.2174/1573413711309020008
A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs
B. Rohit (2013)
10.2147/IJN.S17083
Preparation and evaluation of ofloxacin-loaded palmitic acid solid lipid nanoparticles
Shuyu Xie (2011)
10.2174/138920012800166526
Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
J. Qi (2012)
10.1016/J.JCONREL.2006.10.015
Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants.
B. Petri (2007)
10.1358/MF.2005.27.2.876286
Solid lipid nanoparticles as drug delivery systems.
K. Manjunath (2005)
10.1021/jf9024807
Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers.
V. Gota (2010)
10.46582/jsrm.0702012
Solid Lipid Nanoparticles Regulate Functional Assortment of Mouse Mesenchymal Stem Cells
S. Chabra (2011)
10.1016/J.TUBE.2005.08.009
Oral solid lipid nanoparticle-based antitubercular chemotherapy.
R. Pandey (2005)
10.1208/s12249-010-9410-3
Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles
L. Hu (2010)
10.1023/A:1018888927852
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Shicheng Yang (2004)
10.7150/IJMS.7.398
Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
A. E. Yassin (2010)
10.1155/2012/750891
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
P. Severino (2012)
[Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release].
Y. Chen (2006)
10.1248/CPB.58.650
Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine.
S. Singh (2010)
10.1016/j.ejpb.2007.12.020
Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state.
F. S. Nielsen (2008)
10.1016/J.JCONREL.2004.07.032
Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.
Soo-Jeong Lim (2004)
10.1002/ADMA.200801393
Size-Dependent Endocytosis of Nanoparticles.
Sulin Zhang (2009)
10.1016/J.ADDR.2007.04.011
Solid lipid nanoparticles for targeted brain drug delivery.
P. Blasi (2007)
10.1201/9781420008449.CH1
Nanoparticulate Drug-Delivery Systems: An Overview
Deepak Thassu (2007)
10.1016/J.EJPB.2005.09.003
Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
N. Pedersen (2006)
10.1016/J.JCONREL.2004.02.029
Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes.
K. Tabatt (2004)
10.1208/s12249-009-9235-0
Extended Release Felodipine Self-Nanoemulsifying System
P. Patil (2009)
10.1016/j.ijpharm.2009.08.035
Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies.
Y. Zhao (2010)
10.1016/S0378-5173(02)00003-0
Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation.
S. Nazzal (2002)
10.1038/nrd725
Drug and gene targeting to the brain with molecular trojan horses
W. Pardridge (2002)
Solid lipid nanoparticles (SLN) : an alternative colloidal carrier system for controlled drug delivery
R. Mueller (1995)
10.1016/S0939-6411(02)00083-8
Enhanced brain targeting by synthesis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine and incorporation into solid lipid nanoparticles.
J. X. Wang (2002)
10.1016/S0168-3659(96)01583-0
Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins
D. Crommelin (1997)
10.1007/BF02980228
Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles
Qing-yu Xiang (2007)
10.1038/nrd1033
Effect of pegylation on pharmaceuticals
J. Harris (2003)
10.1211/0022357044959
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
L. Hu (2004)
10.1248/YAKUSHI.128.269
Lipid carriers: a versatile delivery vehicle for proteins and peptides.
M. Rawat (2008)
10.1080/713817583
Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization
V. Jenning (2002)
10.3109/02652049809006847
Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization.
H. Heiati (1998)
10.1201/9781420008449.CH19
Gastrointestinal Applications of Nanoparticulate Drug-Delivery Systems
M. Gasco (2007)
10.1083/JCB.102.5.1738
Stress fibers in the splenic sinus endothelium in situ: molecular structure, relationship to the extracellular matrix, and contractility
D. Drenckhahn (1986)
10.1016/j.ijpharm.2010.03.008
SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization.
E. B. Basalious (2010)
10.1016/j.ejpb.2011.04.012
Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive carotenoid lutein.
S. K. S. Shanmugam (2011)
10.1016/0378-5173(95)00122-Y
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
G. Liversidge (1995)
10.1016/j.ejpb.2009.06.001
Lipid--an emerging platform for oral delivery of drugs with poor bioavailability.
S. Chakraborty (2009)
10.1016/0168-3659(94)90047-7
Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization
C. Schwarz (1994)
10.3109/1061186X.2012.716845
Nanostructured lipid carriers system: Recent advances in drug delivery
M. A. Iqbal (2012)
10.1016/J.IJPHARM.2007.03.009
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
J. Liu (2007)
10.1016/S0939-6411(97)00172-0
Spray-drying of solid lipid nanoparticles (SLN TM).
C. Freitas (1998)
Behaviour of timolol incorporated in lipospheres in the presence of a series of phosphate esters
R. Cavalli (1992)
10.1128/AAC.47.10.3339-3342.2003
Effects of Lipid-Based Oral Formulations on Plasma and Tissue Amphotericin B Concentrations and Renal Toxicity in Male Rats
V. Risovic (2003)
10.1089/rej.2011.1193
Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements.
V. Kakkar (2011)
10.1158/0008-5472.CAN-08-2747
Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.
X. Dong (2009)
10.1007/s11095-006-9180-5
Lipid-based Nanoparticles for Nucleic Acid Delivery
Weijun Li (2006)
10.1002/mnfr.201000310
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
10.1016/J.EJPS.2006.01.001
Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
B. Lu (2006)
10.1016/0378-5173(85)90081-X
Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification
C. Pouton (1985)
10.1016/j.addr.2007.09.007
Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update☆
Natalie L Trevaskis (2008)
Investigation of a new injectable thermosensitive hydrogel loading solid lipid nanoparticles.
X. Guo (2011)
10.1080/10611860600888850
Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration
K. Manjunath (2006)
10.1016/S0378-5173(97)04885-0
Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
A. J. Almeida (1997)
10.1002/JPS.20673
Characterization of prototype self-nanoemulsifying formulations of lipophilic compounds.
F. S. Nielsen (2007)
10.1103/PHYSREVLETT.105.138101
Variable nanoparticle-cell adhesion strength regulates cellular uptake.
Hongyan Yuan (2010)
10.1016/0307-4412(91)90133-s
Liposomes : from biophysics to therapeutics
M. Ostro (1987)
10.1016/S0168-3659(97)00046-1
Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential
K. Westesen (1997)
10.1016/j.bbalip.2011.06.009
Lipid classification, structures and tools.
E. Fahy (2011)
10.1182/BLOOD.V41.4.529.529
The role of the sinus wall in the passage of erythrocytes through the spleen.
L. Chen (1973)
10.1016/J.JCONREL.2004.02.024
Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene-cytotoxicity testing and mouse serum adsorption.
C. Olbrich (2004)
10.3109/03639045.2010.545414
Physicochemical properties of lipid nanoparticles: Effect of lipid and surfactant composition
S. Martins (2011)
10.1016/0006-291X(91)91869-E
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating.
S. Moghimi (1991)
10.2217/nnm.10.126
Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances.
A. Date (2010)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
10.1016/j.biomaterials.2010.06.051
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods.
Y. Qiu (2010)
10.1016/J.IJPHARM.2006.02.019
Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters.
S. Nazzal (2006)
10.1016/j.colsurfb.2011.03.035
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
A. Silva (2011)
10.1016/S0928-0987(00)00081-6
Preparation and characterization of solid lipid nanospheres containing paclitaxel.
R. Cavalli (2000)
10.1080/10611860500071292
Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns
T. Göppert (2005)
10.2174/156720107782151269
Liposomal drug delivery systems: an update review.
A. Samad (2007)
10.1016/j.ijpharm.2009.08.014
Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation.
Z. Wang (2010)
10.1016/S0169-409X(96)00476-0
Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals
A. Gabizon (1997)
10.1358/DOF.2004.029.01.872585
Novel delivery systems for drug targeting to the brain
J. S. Reddy (2004)
10.1023/A:1012043315093
Cytotoxicity of Solid Lipid Nanoparticles as a Function of the Lipid Matrix and the Surfactant
R. Mueller (2004)
10.1016/J.JBIOTEC.2004.06.007
Challenges and solutions for the delivery of biotech drugs--a review of drug nanocrystal technology and lipid nanoparticles.
R. H. Muller (2004)
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
B. Siekmann (1996)
10.1016/j.jconrel.2008.10.002
Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
Houli Li (2009)
10.2174/156720108785915087
Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
S. Shidhaye (2008)
10.1016/0026-2862(87)90061-6
The Microcirculatory Society Eugene M. Landis award lecture. Microcirculation of the spleen: new concepts, new challenges.
A. C. Groom (1987)
10.1016/S0142-9612(01)00362-3
Production of lipospheres as carriers for bioactive compounds.
R. Cortesi (2002)
10.1016/j.ejps.2012.05.012
Comparison of toxicokinetic and tissue distribution of triptolide-loaded solid lipid nanoparticles vs free triptolide in rats.
Mei Xue (2012)
10.1021/bc900150v
Physico-chemical characterization of polylipid nanoparticles for gene delivery to the liver.
Maung T Nyunt (2009)
10.1080/10937404.2011.615113
Toxicology of Nanomaterials Used in Nanomedicine
J. Zhao (2011)
10.2174/1874126600802010026
Effect of Lipophilicity of Dispersed Drugs on the Physicochemical and Technological Properties of Solid Lipid Nanoparticles
A. H. Stancampiano (2008)
10.1016/j.jconrel.2012.06.002
Improvement of drug safety by the use of lipid-based nanocarriers.
S. B. Lim (2012)
10.1021/NL070363Y
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes.
B. Chithrani (2007)
10.1073/PNAS.0503879102
Mechanics of receptor-mediated endocytosis.
H. Gao (2005)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1021/nn800532m
Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles.
Hong Jin (2009)
10.3109/08982100903161456
Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles
J. Varshosaz (2010)
10.1016/j.ijpharm.2012.04.001
Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil.
A. Villar (2012)
10.1016/S0939-6411(00)00089-8
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs.
T. Gershanik (2000)
10.1016/J.JCONREL.2004.07.019
Negative preclinical results with stealth nanospheres-encapsulated Doxorubicin in an orthotopic murine brain tumor model.
I. Brigger (2004)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar